- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Irritable Bowel Syndrome (IBS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Irritable Bowel Syndrome (IBS) size is estimated to be xx million in 2021 from USD 3441.8 million in 2020, with a change of XX% between 2020 and 2021. The global Irritable Bowel Syndrome (IBS) market size is expected to grow at a CAGR of 7.3% for the next five years.
Market segmentation
Irritable Bowel Syndrome (IBS) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IBS-D Drug
IBS-C Drug
Other
Market segment by Application can be divided into
Women
Men
The key market players for global Irritable Bowel Syndrome (IBS) market are listed below:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Irritable Bowel Syndrome (IBS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Irritable Bowel Syndrome (IBS), with price, sales, revenue and global market share of Irritable Bowel Syndrome (IBS) in 2018 and 2019.
Chapter 3, the Irritable Bowel Syndrome (IBS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irritable Bowel Syndrome (IBS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Irritable Bowel Syndrome (IBS) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Irritable Bowel Syndrome (IBS) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Women
1.3.3 Men
1.4 Global Irritable Bowel Syndrome (IBS) Market Size & Forecast
1.4.1 Global Irritable Bowel Syndrome (IBS) Sales in Value (2016-2026))
1.4.2 Global Irritable Bowel Syndrome (IBS) Sales in Volume (2016-2026)
1.4.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2026) & (USD/K Units)
1.5 Global Irritable Bowel Syndrome (IBS) Production Capacity Analysis
1.5.1 Global Irritable Bowel Syndrome (IBS) Total Production Capacity (2016-2026)
1.5.2 Global Irritable Bowel Syndrome (IBS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Irritable Bowel Syndrome (IBS) Market Drivers
1.6.2 Irritable Bowel Syndrome (IBS) Market Restraints
1.6.3 Irritable Bowel Syndrome (IBS) Trends Analysis
2 Manufacturers Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
2.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Irritable Bowel Syndrome (IBS) Product and Services
2.2.4 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Irritable Bowel Syndrome (IBS) Product and Services
2.3.4 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sucampo Pharmaceuticals (Mallinckrodt)
2.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Details
2.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Major Business
2.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
2.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sebela Pharmaceuticals Inc
2.5.1 Sebela Pharmaceuticals Inc Details
2.5.2 Sebela Pharmaceuticals Inc Major Business
2.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
2.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Astellas Pharmaceuticals
2.6.1 Astellas Pharmaceuticals Details
2.6.2 Astellas Pharmaceuticals Major Business
2.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
2.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Irritable Bowel Syndrome (IBS) Sales by Manufacturer
3.1 Global Irritable Bowel Syndrome (IBS) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Irritable Bowel Syndrome (IBS)
3.4 Market Concentration Rate
3.4.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
3.4.2 Top 6 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
3.5 Global Irritable Bowel Syndrome (IBS) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Irritable Bowel Syndrome (IBS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales in Volume by Region (2016-2026)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2026)
4.2 North America Irritable Bowel Syndrome (IBS) Revenue (2016-2026)
4.3 Europe Irritable Bowel Syndrome (IBS) Revenue (2016-2026)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (2016-2026)
4.5 South America Irritable Bowel Syndrome (IBS) Revenue (2016-2026)
4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Irritable Bowel Syndrome (IBS) Sales in Volume by Type (2016-2026)
5.2 Global Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2026)
5.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Irritable Bowel Syndrome (IBS) Sales in Volume by Application (2016-2026)
6.2 Global Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2026)
6.3 Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2026)
7.2 North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2026)
7.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country
7.3.1 North America Irritable Bowel Syndrome (IBS) Sales in Volume by Country (2016-2026)
7.3.2 North America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2026)
8.2 Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2026)
8.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
8.3.1 Europe Irritable Bowel Syndrome (IBS) Sales in Volume by Country (2016-2026)
8.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2016-2026)
9.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2016-2026)
9.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
9.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2026)
10.2 South America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2026)
10.3 South America Irritable Bowel Syndrome (IBS) Market Size by Country
10.3.1 South America Irritable Bowel Syndrome (IBS) Sales in Volume by Country (2016-2026)
10.3.2 South America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2026)
11.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2026)
11.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
11.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Irritable Bowel Syndrome (IBS) Typical Distributors
12.3 Irritable Bowel Syndrome (IBS) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Irritable Bowel Syndrome (IBS) Revenue by Application, (USD Million), 2021-2026
Table 3. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 4. Bausch Health Major Business
Table 5. Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
Table 6. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Irritable Bowel Syndrome (IBS) Product and Services
Table 10. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Irritable Bowel Syndrome (IBS) Product and Services
Table 14. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sucampo Pharmaceuticals (Mallinckrodt) Basic Information, Manufacturing Base and Competitors
Table 16. Sucampo Pharmaceuticals (Mallinckrodt) Major Business
Table 17. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
Table 18. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sebela Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Sebela Pharmaceuticals Inc Major Business
Table 21. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
Table 22. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Astellas Pharmaceuticals Major Business
Table 25. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
Table 26. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2019-2021e) & (Million Units)
Table 28. Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Irritable Bowel Syndrome (IBS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Irritable Bowel Syndrome (IBS) Production Capacity by Company, (Million Units): 2020 VS 2021
Table 31. Head Office and Irritable Bowel Syndrome (IBS) Production Site of Key Manufacturer
Table 32. Irritable Bowel Syndrome (IBS) New Entrant and Capacity Expansion Plans
Table 33. Irritable Bowel Syndrome (IBS) Mergers & Acquisitions in the Past Five Years
Table 34. Global Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021e) & (Million Units)
Table 35. Global Irritable Bowel Syndrome (IBS) Sales by Region (2021-2026) & (Million Units)
Table 36. Global Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021e) & (USD Million)
Table 37. Global Irritable Bowel Syndrome (IBS) Revenue by Region (2021-2026) & (USD Million)
Table 38. Global Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 39. Global Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 40. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021e) & (USD Million)
Table 41. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2021-2026) & (USD Million)
Table 42. Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2021e) & (USD/K Units)
Table 43. Global Irritable Bowel Syndrome (IBS) Price by Type (2021-2026) & (USD/K Units)
Table 44. Global Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 45. Global Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 46. Global Irritable Bowel Syndrome (IBS) Revenue by Application (2016-2021e) & (USD Million)
Table 47. Global Irritable Bowel Syndrome (IBS) Revenue by Application (2021-2026) & (USD Million)
Table 48. Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2021e) & (USD/K Units)
Table 49. Global Irritable Bowel Syndrome (IBS) Price by Application (2021-2026) & (USD/K Units)
Table 50. North America Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021e) & (Million Units)
Table 51. North America Irritable Bowel Syndrome (IBS) Sales by Country (2021-2026) & (Million Units)
Table 52. North America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021e) & (USD Million)
Table 53. North America Irritable Bowel Syndrome (IBS) Revenue by Country (2021-2026) & (USD Million)
Table 54. North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 55. North America Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 56. North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 57. North America Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 58. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021e) & (Million Units)
Table 59. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2021-2026) & (Million Units)
Table 60. Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021e) & (USD Million)
Table 61. Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2021-2026) & (USD Million)
Table 62. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 63. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 64. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 65. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 66. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021e) & (Million Units)
Table 67. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2021-2026) & (Million Units)
Table 68. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021e) & (USD Million)
Table 69. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Region (2021-2026) & (USD Million)
Table 70. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 71. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 72. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 73. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 74. South America Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021e) & (Million Units)
Table 75. South America Irritable Bowel Syndrome (IBS) Sales by Country (2021-2026) & (Million Units)
Table 76. South America Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021e) & (USD Million)
Table 77. South America Irritable Bowel Syndrome (IBS) Revenue by Country (2021-2026) & (USD Million)
Table 78. South America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 79. South America Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 80. South America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 81. South America Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 82. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021e) & (Million Units)
Table 83. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Country (2021-2026) & (Million Units)
Table 84. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021e) & (USD Million)
Table 85. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2021-2026) & (USD Million)
Table 86. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021e) & (Million Units)
Table 87. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Type (2021-2026) & (Million Units)
Table 88. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021e) & (Million Units)
Table 89. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Application (2021-2026) & (Million Units)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Irritable Bowel Syndrome (IBS) Typical Distributors
Table 93. Irritable Bowel Syndrome (IBS) Typical Customers
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 3. IBS-D Drug
Figure 4. IBS-C Drug
Figure 5. Other
Figure 6. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 7. Women
Figure 8. Men
Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size, (USD Million) & (Million Units): 2020 VS 2021 VS 2026
Figure 10. Global Irritable Bowel Syndrome (IBS) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Irritable Bowel Syndrome (IBS) Sales (2016-2026) & (Million Units)
Figure 12. Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2026) & (USD/K Units)
Figure 13. Global Irritable Bowel Syndrome (IBS) Production Capacity (2016-2026) & (Million Units)
Figure 14. Global Irritable Bowel Syndrome (IBS) Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Irritable Bowel Syndrome (IBS) Market Drivers
Figure 16. Irritable Bowel Syndrome (IBS) Market Restraints
Figure 17. Irritable Bowel Syndrome (IBS) Market Trends
Figure 18. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2020
Figure 19. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2020
Figure 20. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2026)
Figure 24. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2026)
Figure 25. North America Irritable Bowel Syndrome (IBS) Revenue (2016-2026) & (USD Million)
Figure 26. Europe Irritable Bowel Syndrome (IBS) Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue (2016-2026) & (USD Million)
Figure 28. South America Irritable Bowel Syndrome (IBS) Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue (2016-2026) & (USD Million)
Figure 30. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2026)
Figure 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2026)
Figure 32. Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2026) & (USD/K Units)
Figure 33. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 34. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2026)
Figure 35. Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2026) & (USD/K Units)
Figure 36. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2026)
Figure 37. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 38. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2026)
Figure 39. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2026)
Figure 40. United States Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2026)
Figure 44. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 45. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2026)
Figure 46. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2026)
Figure 47. Germany Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2026)
Figure 56. China Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2026)
Figure 63. South America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 64. South America Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2026)
Figure 65. South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
